Azapteridine inhibitors of hepatitis C virus RNA-dependent RNA polymerase

Letters in Drug Design and Discovery

Volumn 4, Issue 1, 2007, Pages 1-8

  Middleton, T ^a   Lim, H B ^a   Montgomery, D ^a   Rockway, T ^a   Liu, D ^a   Klein, L ^a   Qin, W ^a   Harlan, J E ^a   Kati, W M ^a   Molla, A ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Azapteridine; Hepatitis C virus; RNA dependent RNA polymerase; Toxoflavin

Indexed keywords

A 598949; A 765799; ANTIBIOTIC AGENT; AZAPTERIDINE; DITHIOTHREITOL; ENZYME INHIBITOR; QUERCETIN; REUMYCIN; RNA DIRECTED RNA POLYMERASE; UNCLASSIFIED DRUG; XANTHOTHRICIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SPECIFICITY; DRUG STRUCTURE; ENZYME BINDING; ENZYME INHIBITION; ENZYME PURIFICATION; HELA CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 33845966782     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018007778992937     Document Type: Article

References (15)

1. Lavanchy, D.; McMahon, B. In Hepatitis C; J.T. Liang and J.H. Hoofnagle, Eds; Academic Press:, San Diego, 2000; pp. 185-202.
2. Kenny-Walsh, E. Clin. Liver Dis., 2001, 5, 969-77.
3. Fried, M.W. Hepatology, 2002, 36, S237-44.
4. De Francesco, R.; Tomei, L.; Altamura, S.; Summa, V.; Migliaccio, G. Antiviral Res., 2003, 58, 1-16.
5. Bressanelli, S.; Tomei, L.; Rey, F.A.; De Francesco, R. J. Virol., 2002, 76, 3482-3492.
6. Lesburg, C.A.; Cable, M.B.; Ferrari, E.; Hong, Z.; Mannarino, A.F.; Weber, P.C. Nat. Struct. Biol., 1999, 6, 937-43.
7. Labonte, P.; Axelrod, V.; Agarwal, A.; Aulabaugh, A.; Amin, A.; Mak, P. J. Biol. Chem., 2002, 277, 38838-46.
8. Adachi, T.; Ago, H.; Habuka, N.; Okuda, K.; Komatsu, M.; Ikeda, S.; Yatsunami, K. Biochim. Biophys. Acta, 2002, 1601, 38-48.
9. Wang, M.; Ng, K.K.; Cherney, M.M.; Chan, L.; Yannopoulos, C.G.; Bedard, J.; Morin, N.; Nguyen-Ba, N.; Alaoui-Ismaili, M.H.; Bethell, R.C.; James, M.N. J. Biol. Chem., 2003, 278, 9489-95.
10. Harlan, J.E.; Egan, D.A.; Ladror, U.S.; Snyder, S.; Tang, M.l.; A., B.; Holzman, T.F.; Assay Drug Dev. Technol., 2003, 1, 507-519.
11. Sepehri, S.; Hernandez, N.; Genome, 1997, 7, 1006-19.
12. Nagamatsu, T.; Yamasaki, H.; T., H.; Yamato, M.; Kido, Y.; Shibata, M.; Yoneda, F. Chem. Pharm. Bull., 1993, 41, 362-368.
13. Ding, Y.; Girardet, J.L.; Smith, K.L.; Larson, G.; Prigaro, B.; Lai, V.C.H.; Zhong, W.D.; Wu, J.Z. Bioorg. Med. Chem. Lett., 2005, 15, 675-678.
14. Latuasan, H.E.; Berends, W. Biochim. Biophys. Acta, 1961, 52, 502-508.
15. Wang, Z.; Ma, M.; Wang, R. Br. J. Pharmacol., 1996, 117, 293-8.